According to the research report titled ‘Global Single Dose Radiotherapy Services Market Size study, by Service (Hospitals, Radiotherapy Centers, Specialized Cancer Institutes), by Therapy (External Beam Radiotherapy, Internal Beam Radiotherapy) and Regional Forecasts 2021-2027’, available with the MarketStudyReport, global single dose radiotherapy services market is expected to register considerable growth during 2021-2027.
 

The rapid expansion of global single dose radiotherapy services market is primarily driven by increasing number of cancer patients and a growing elderly population. In addition, growing popularity of intraoperative radiation therapy is also expected to contribute towards the overall market remuneration.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4566303/
 

For those uninitiated, single-dose radiotherapy allows for direct irradiation of the tumor site. Since only the tumor bed is irradiated, the patient's skin is not exposed to radiation, which in turn minimizes potential side effects associated with future dermal. However, a lack of skilled professionals is likely to impede the market growth during the forecast period.
 

Moving on to the segmental analysis, the marketplace is fragmented by service and therapy landscape. By service, global single dose radiotherapy services industry is classified into specialized cancer institutes, radiotherapy centers, and hospitals. In terms of therapy, the market is divided into internal beam radiotherapy and external beam radiotherapy.
 

The geographical analysis of the global single dose radiotherapy service industry includes Europe, North America, Latin America, Asia-Pacific, and the rest of the world.
 

Among these, North America leads in terms of market share, primarily due to the high occurrence of breast and prostate cancer, increased adoption of single-line radiation therapy because of its multiple benefits, and easy availability of technologically advanced radiation therapy equipment.
 

Meanwhile, Asia-Pacific market is also expected to develop at the fastest rate through the projection period. Favorable reimbursement policies, growing awareness regarding the benefits of single-dose radiotherapy, and an increasing number of radiotherapy centers will all contribute to the single dose radiotherapy services industry growth in Asia-Pacific.
 

Key industry players found to be operating in this market are Bionpharma Inc., Extend Biosciences Inc., Prolynx Inc., F. Hoffmann-La Roche AG, Ascendis Pharma, Amgen Inc., Entera Bio Ltd., Takeda Pharmaceutical Company Limited, NPS Pharmaceuticals Inc., and Becton, Dickinson, and Company.